MACFARLANE M DAVID 4
4 · TITAN PHARMACEUTICALS INC · Filed Apr 19, 2011
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
MACFARLANE M DAVID
Director
Transactions
- Award
Option to Purchase Common Stock
2011-04-15+30,000→ 30,000 totalExercise: $1.40Exp: 2021-04-15→ Common Stock (30,000 underlying) - Award
Option to Purchase Common Stock
2011-04-15+20,000→ 20,000 totalExercise: $1.40From: 2011-04-15Exp: 2021-04-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest in 12 equal monthly installments beginning on the grant date.